As Ozempic, Wegovy, Mounjaro and other injectable diabetes and weight-loss medications continue to make headlines for the successes and challenges many see with the medications for obesity and metabolic conditions, questions — regarding impacts on pregnant persons, potential uses for other medical conditions, concerns over counterfeit products that have flooded the market, discussions over what these mean for those with histories of disordered eating and more — continue to emerge.
On Monday, March 18, 2024, experts from the University of Maryland, Baltimore (UMB) met with members of the press for a virtual press briefing to discuss these topics and more. UMB’s renowned experts from its Schools of Medicine, Pharmacy, and Social Work provided important updates and insights on various aspects of these medications and their impact on patients.This panel discussion includes:• Experts from University of Maryland Baltimore discuss various medications and their effects• Discussion on the limitations of previous weight loss medications and their side effects• Explanation of how GLP-1 agonists work to control blood glucose levels and decrease hunger• Emphasis on the importance of treating obesity as a chronic disease and the benefits of doing so
More from Youtube
- 1:01:47Virtual Face to Face: Facing the Future Together: A Conversation with Presidents Jarrell and PinesOn June 26, 2025 University of Maryland, Baltimore President Bruce Jarrell and University of Maryland, College Park President Darryll Pines discussed the challenges facing higher education today and how they are working together to overcome them. In this Virtual Face to Face program a live audience was able to pose questions about university-based research, international students, student finance, and more.
- 3:50Hitting the Brakes on Dangerous Inflammation | Breakthroughs Can't WaitCould a new class of drugs rebalance the body and prevent excessive inflammation?Paul Shapiro, PhD, professor at the University of Maryland School of Pharmacy and partner Jeffrey Hasday, MD, professor at the University of Maryland School of Medicine are developing a class of drugs that may be able to reset the natural balance of inflammation and prevent a number of serious diseases. The secret is protein kinases, enzymes that regulate how various proteins interact and alter how they function.🧪 Breakthroughs Can’t Wait: UMB research drives innovation, improves lives, and tackles global challenges. But we can’t do it without continued support.🔗 Learn more and support research that saves lives: https://www.umaryland.edu/breakthroughs#BreakthroughsCantWaitUMB #InflammationResearch #DrugDiscovery #ProteinKinase, #MedicalBreakthrough #ChronicInflammation #BiomedicalResearch #PharmaceuticalScience #TranslationalMedicine #UMBresearch #EnzymeTherapy #InflammationTreatment, #FutureOfMedicine #LifeSavingResearch, #HealthInnovation
- 0:34How Modulating Protein Kinases May Help Alleviate DiseaseProtein kinases help regulate inflammation — but what happens when their activity goes unchecked?At the University of Maryland, Baltimore, researchers Paul Shapiro, PhD, and Jeffrey Hasday, MD, are exploring how adjusting kinase activity may help reduce the severity of inflammation-related diseases.Watch how this breakthrough could lead to new strategies for improving long-term health. #ProteinKinases #HealthResearch #PharmacyInnovation #InflammationScience #MedicalBreakthrough #BreakthroughsCantWaitUMB
- 0:40Balancing Inflammation: Hope for Reducing ARDS ComplicationsWhat if we could help the body manage inflammation before it becomes dangerous? At the University of Maryland, Baltimore, researchers Paul Shapiro, PhD, and Jeffrey Hasday, MD, are studying protein kinases — enzymes that regulate immune signaling. Their work could lead to breakthroughs in reducing acute respiratory distress syndrome (ARDS) and related health issues.#BreakthroughsCantWaitUMB #ARDS #MedicalResearch #Inflammation #PharmaceuticalScience #ImmuneBalance #BreakthroughsCantWaitUMB
- 0:57Anti-Inflammatory Drug Offers Hope | Breakthroughs Can't WaitWhat if we could reset the balance between inflammation and anti-inflammation in the body?That’s exactly what researchers Paul Shapiro, PhD (University of Maryland School of Pharmacy), and Jeffrey Hasday, MD (University of Maryland School of Medicine), are working toward.By exploring protein kinases—enzymes involved in regulating inflammation—they’re investigating ways to support long-term health and conditions related to immune overreaction, such as respiratory and muscular disorders.#BreakthroughsCantWaitUMB #InflammationResearch #ChronicPain #NIH
- 1:02UMB Graduate Reflections: Lia Mejia, MSW '25Lia Mejia, MSW '25, reflects on the advice to keep herself grounded in this conversation with University of Maryland, Baltimore Provost and VP Dr. Roger J. Ward, EdD, JD, MSL, MPA. Mejia graduated this spring from the University of Maryland School of Social Work with her master's degree.#Classof2025 #UMBgrad #SocialWork
